medac Gesellschaft für klinische Spezialpräparate mbH
发明人:
申请号：
NO2019032
公开号：
NO2019032I1
申请日:
2019.07.23
申请国别(地区):
NO
年份:
2019
代理人:
摘要：
The invention relates to the use of treosulfan as a conditioning agent before allogenic transplantation of bone marrow or haematopoietic stem cells, whereby treosulfan is administered, either as single effective agent, or in combination with other chemotherapetic agents or immunosuppressant agents.
